April 25 (Reuters) - Biomarin Pharmaceutical Inc:
* Q1 REVENUE $373.4 MILLION VERSUS I/B/E/S VIEW $348.7 MILLION
* Q1 EARNINGS PER SHARE VIEW $-0.17 -- THOMSON REUTERS I/B/E/S
* AS OF MARCH 31, 2018, BIOMARIN HAD CASH, CASH EQUIVALENTS AND INVESTMENTS TOTALING ABOUT $1.7 BILLION Source text for Eikon: Further company coverage: